Crinetics Pharmaceuticals
CRNX
CRNX
63 hedge funds and large institutions have $473M invested in Crinetics Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
+1
Holders Change %
+1.61%
% of All Funds
1.37%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
11
Increased
30
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
$20.1M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
$12.3M |
| 3 |
Goldman Sachs
New York
|
$4.53M |
| 4 |
BlackRock
New York
|
$23.3M |
| 5 |
O
OrbiMed
New York
|
$51M |
